Clinics that can address post-GLP-1 treatment challenges will stand out in a crowded marketplace ahead of the competition
Two drugmakers are now offering a new generation of these GLP-1 drugs, whose effects on weight loss have been spectacular
GLP-1 suppresses gastrointestinal motility and inhibits the migrating motor complex in healthy subjects and patients with irritable bowel syndrome
Members are encouraged to build strength, protect muscle, stay nourished, and develop habits that support long-term health even after weight loss slows
This delay means you feel fuller for longer after a meal, naturally reducing the desire to eat more
Clinical trials show that patients typically experience weight loss of about 5% to 10% of their initial body weight over several months, which translates to approximately 4 to 8 pounds per month for many individuals